Document is current
Any future updates will be listed below
-
Authors
Mitchell, Aaron P.
Dey, Pranammya
Ohn, Jennifer A.
Tabatabai, Sara M.
Curry, Michael A.
Bach, Peter B.
- License Information
-
More Information
Article History
First Online: 23 March 2020
Compliance with Ethical Standards
:
: This research did not receive dedicated funding.
: APM discloses receipt of a research abstract award from the Conquer Cancer Foundation, which was partially funded by Merck. PBB discloses grants from Kaiser Permanente and the Laura and John Arnold Foundation; personal payments from the American Society for Health-System Pharmacists, Gilead Pharmaceuticals, WebMD, Goldman Sachs, Morgan Stanley, Defined Health, Vizient, Anthem, Excellus Health Plan, Hematology Oncology Pharmacy Association, NYS Rheumatology Society, Novartis Pharmaceuticals, Janssen Pharmaceuticals, Third Rock Ventures, JMP Securities, Genentech, Mercer, United Rheumatology, Oppenheimer & Co., Cello Health, and Oncology Analytics; and consulting fees from Foundation Medicine and Grail. PD, JAO, SMT, and MAC have no potential conflicts of interest to disclose.
: The data that support these findings are publicly available from the following sources: NCCN Evidence Blocks, from the National Comprehensive Cancer Network (); Medicare pricing for physician-administered drugs, from the 2019 ASP files (); Medicare pricing for oral drugs, from Medicare.gov Planfinder (). Aggregated data are available from the corresponding author on reasonable request.
